Ardelyx's (NASDAQ:ARDX) Investors Will Be Pleased With Their Favorable 91% Return Over the Last Five Years
Yahoo FinanceApr 23 14:38 ET
Piper Sandler Sticks to Its Buy Rating for Ardelyx (ARDX)
TipRanksApr 22 08:27 ET
Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
Conference call scheduled for 4:30 p.m. Eastern TimeWALTHAM, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, d
GlobeNewswireApr 18 08:00 ET
Ardelyx(ARDX.US) Officer Sells US$52,923.75 in Common Stock
$Ardelyx(ARDX.US)$ Officer RAAB MICHAEL sold 7,500 shares of common stock on Apr 15, 2024 at an average price of $7.0565 for a total value of $52,923.75.Source: Announcement What is statement of chang
moomoo NewsApr 17 17:03 ET
Ardelyx Is Maintained at Outperform by Wedbush
Ardelyx Is Maintained at Outperform by Wedbush
Dow JonesApr 17 13:03 ET
Express News | Wedbush Maintains Outperform on Ardelyx, Raises Price Target to $14
Moomoo 24/7Apr 17 12:54 ET
Insiders At Ardelyx Sold US$1.1m In Stock, Alluding To Potential Weakness
Ardelyx, Inc. (NASDAQ:ARDX) shareholders may have reason to be concerned, as several insiders sold their shares over the past year. When analyzing insider transactions, it is usually more valuable t
Simply Wall StApr 17 07:03 ET
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Shares of Byrna Technologies Inc. (NASDAQ:BYRN) rose sharply during Friday's session after the company reported better-than-expected first-quarter revenue, and announced a CFO transition. Byrna Techno
BenzingaApr 5 13:06 ET
Express News | Ardelyx Shares Are Trading Higher After Leerink Partners Initiated Coverage on the Stock With an Outperform Rating and $14 Price Target
Moomoo 24/7Apr 5 10:06 ET
Ardelyx Initiated at Outperform by Leerink Partners
Ardelyx Initiated at Outperform by Leerink Partners
Dow JonesApr 5 08:07 ET
A Closer Look at 6 Analyst Recommendations For Ardelyx
Analysts' ratings for Ardelyx (NASDAQ:ARDX) over the last quarter vary from bullish to bearish, as provided by 6 analysts.The table below provides a snapshot of their recent ratings, showcasing how se
BenzingaApr 5 08:00 ET
Express News | Leerink Partners Initiates Coverage On Ardelyx With Outperform Rating, Announces Price Target of $14
Moomoo 24/7Apr 5 07:57 ET
Ardelyx Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/05/2024 91.78% Leerink Partners → $14 Initiates Coverage On → Outperform 02/23/2024 105.48% Piper Sandl
BenzingaApr 5 07:56 ET
Ardelyx(ARDX.US) Officer Sells US$11,096.58 in Common Stock
$Ardelyx(ARDX.US)$ Officer RAAB MICHAEL sold 1,518 shares of Common Stock on Apr 1, 2024 at an average price of $7.31 for a total value of $11,096.58.Source: Announcement What is statement of changes
moomoo NewsApr 2 16:49 ET
Ardelyx: Kelliher Served as Group Vice Pres, M&A and Business Development, at Horizon Therapeutics >ARDX
Ardelyx: Kelliher Served as Group Vice Pres, M&A and Business Development, at Horizon Therapeutics >ARDX
Dow JonesMar 25 08:01 ET
Ardelyx Appoints Mike Kelliher, as Executive Vice Pres, Corporate Development and Strategy
Ardelyx Appoints Mike Kelliher, as Executive Vice Pres, Corporate Development and Strategy
Dow JonesMar 25 08:01 ET
Ardelyx(ARDX.US) Officer Sells US$664.98K in Common Stocks
$Ardelyx(ARDX.US)$ Officer GRAMMER ELIZABETH A sold 86,000 shares of Common Stocks on Mar 20, 2024 at an average price of $7.7323 for a total value of $664.98K.Source: Announcement What is statement o
moomoo NewsMar 22 17:22 ET
Ardelyx Insider Sold Shares Worth $664,978, According to a Recent SEC Filing
Elizabeth A Grammer, Chief Legal and Administrative Officer, on March 20, 2024, sold 86,000 shares in Ardelyx (ARDX) for $664,978. Following the Form 4 filing with the SEC, Grammer has control over a
MT NewswiresMar 22 16:47 ET
Institutional Investors May Overlook Ardelyx, Inc.'s (NASDAQ:ARDX) Recent US$195m Market Cap Drop as Long-term Gains Remain Positive
Yahoo FinanceMar 21 10:38 ET
When Will Ardelyx, Inc. (NASDAQ:ARDX) Turn A Profit?
We feel now is a pretty good time to analyse Ardelyx, Inc.'s (NASDAQ:ARDX) business as it appears the company may be on the cusp of a considerable accomplishment. Ardelyx, Inc., a biopharmaceutical
Simply Wall StMar 21 07:02 ET
No Data
No Data